Knowledge atlas of antibody-drug conjugates on CiteSpace and clinical trial visualization analysis

OBJECTIVE: Antibody-drugs conjugates (ADCs) are novel drugs with highly targeted and tumor-killing abilities and developing rapidly. This study aimed to evaluate drug discovery and clinical trials of and explore the hotspots and frontiers from 2012 to 2022 using bibliometric methods. METHODS: Public...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Peizhuo, Zhang, Yinbin, Zhang, Shuqun, Wei, Xinyu, Liu, Yanbin, Du, Chong, Hu, Mingyou, Feng, Cong, Li, Jia, Zhao, Fang, Li, Chaofan, Li, Zhen, Du, Lisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850101/
https://www.ncbi.nlm.nih.gov/pubmed/36686767
http://dx.doi.org/10.3389/fonc.2022.1039882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850101/
https://www.ncbi.nlm.nih.gov/pubmed/36686767
http://dx.doi.org/10.3389/fonc.2022.1039882

Ejemplares similares